I just worry that the headline/photo here is misleading
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
For those experiencing chronic fatigue or unexplained symptoms, our clinicians thoroughly assess for potential vitamin deficiencies, including B12
The peptide activates GLP-1 receptors, which reduce your appetite and slow down digestion
The shorthand 5-Amino-1MQ describes a quinolinium scaffold bearing a methyl substituent at the ring nitrogen (1-methylquinolinium) and an amino group at the 5-position
It is used to prevent and to treat vitamin B12 deficiency
